The global market for Pirfenidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pirfenidone(CAS：53179-13-8) is a medication used for the treatment of idiopathic pulmonary fibrosis.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pirfenidone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pirfenidone API.

The Pirfenidone API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pirfenidone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pirfenidone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pirfenidone API Market Report

Report Metric	Details
Report Name	Pirfenidone API Market
CAGR	5%
by Type	Above 98 % Above 99 %
by Application	Tablets Capsules Others
Production by Region	North America Europe China India Mexico
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mylan, Apotex Pharmachem, Aurobindo Pharma Limited, Chemeca Drugs, CHEMO, Glenmark Pharmaceuticals, Hetero Drugs, HONOUR LAB LTD, Jubilant Generics, Laurus Labs, Lupin Ltd, Micro Labs Limited, NEWEDGE Overseas, Optimus Pharma, Raks Pharma, Shilpa Medicare, SMS Pharmaceuticals, Veranova, Signa S.A. de C.V., Guangzhou Tosun Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pirfenidone API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pirfenidone API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pirfenidone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pirfenidone API Market report?

Ans: The main players in the Pirfenidone API Market are Mylan, Apotex Pharmachem, Aurobindo Pharma Limited, Chemeca Drugs, CHEMO, Glenmark Pharmaceuticals, Hetero Drugs, HONOUR LAB LTD, Jubilant Generics, Laurus Labs, Lupin Ltd, Micro Labs Limited, NEWEDGE Overseas, Optimus Pharma, Raks Pharma, Shilpa Medicare, SMS Pharmaceuticals, Veranova, Signa S.A. de C.V., Guangzhou Tosun Pharmaceutical

What are the Application segmentation covered in the Pirfenidone API Market report?

Ans: The Applications covered in the Pirfenidone API Market report are Tablets, Capsules, Others

What are the Type segmentation covered in the Pirfenidone API Market report?

Ans: The Types covered in the Pirfenidone API Market report are Above 98 %, Above 99 %

1 Pirfenidone API Market Overview

1.1 Product Definition

1.2 Pirfenidone API by Type

1.2.1 Global Pirfenidone API Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Above 98 %

1.2.3 Above 99 %

1.3 Pirfenidone API by Application

1.3.1 Global Pirfenidone API Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

1.4.2 Global Pirfenidone API Production Capacity Estimates and Forecasts (2020-2031)

1.4.3 Global Pirfenidone API Production Estimates and Forecasts (2020-2031)

1.4.4 Global Pirfenidone API Market Average Price Estimates and Forecasts (2020-2031)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Pirfenidone API Production Market Share by Manufacturers (2020-2025)

2.2 Global Pirfenidone API Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Pirfenidone API, Industry Ranking, 2023 VS 2024

2.4 Global Pirfenidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Pirfenidone API Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Pirfenidone API, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Pirfenidone API, Product Offered and Application

2.8 Global Key Manufacturers of Pirfenidone API, Date of Enter into This Industry

2.9 Pirfenidone API Market Competitive Situation and Trends

2.9.1 Pirfenidone API Market Concentration Rate

2.9.2 Global 5 and 10 Largest Pirfenidone API Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Pirfenidone API Production by Region

3.1 Global Pirfenidone API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Pirfenidone API Production Value by Region (2020-2031)

3.2.1 Global Pirfenidone API Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Pirfenidone API by Region (2026-2031)

3.3 Global Pirfenidone API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Pirfenidone API Production Volume by Region (2020-2031)

3.4.1 Global Pirfenidone API Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Pirfenidone API by Region (2026-2031)

3.5 Global Pirfenidone API Market Price Analysis by Region (2020-2025)

3.6 Global Pirfenidone API Production and Value, Year-over-Year Growth

3.6.1 North America Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

3.6.4 India Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

3.6.5 Mexico Pirfenidone API Production Value Estimates and Forecasts (2020-2031)

4 Pirfenidone API Consumption by Region

4.1 Global Pirfenidone API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Pirfenidone API Consumption by Region (2020-2031)

4.2.1 Global Pirfenidone API Consumption by Region (2020-2025)

4.2.2 Global Pirfenidone API Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Pirfenidone API Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Pirfenidone API Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Pirfenidone API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Pirfenidone API Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Pirfenidone API Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Pirfenidone API Production by Type (2020-2031)

5.1.1 Global Pirfenidone API Production by Type (2020-2025)

5.1.2 Global Pirfenidone API Production by Type (2026-2031)

5.1.3 Global Pirfenidone API Production Market Share by Type (2020-2031)

5.2 Global Pirfenidone API Production Value by Type (2020-2031)

5.2.1 Global Pirfenidone API Production Value by Type (2020-2025)

5.2.2 Global Pirfenidone API Production Value by Type (2026-2031)

5.2.3 Global Pirfenidone API Production Value Market Share by Type (2020-2031)

5.3 Global Pirfenidone API Price by Type (2020-2031)

6 Segment by Application

6.1 Global Pirfenidone API Production by Application (2020-2031)

6.1.1 Global Pirfenidone API Production by Application (2020-2025)

6.1.2 Global Pirfenidone API Production by Application (2026-2031)

6.1.3 Global Pirfenidone API Production Market Share by Application (2020-2031)

6.2 Global Pirfenidone API Production Value by Application (2020-2031)

6.2.1 Global Pirfenidone API Production Value by Application (2020-2025)

6.2.2 Global Pirfenidone API Production Value by Application (2026-2031)

6.2.3 Global Pirfenidone API Production Value Market Share by Application (2020-2031)

6.3 Global Pirfenidone API Price by Application (2020-2031)

7 Key Companies Profiled

7.1 Mylan

7.1.1 Mylan Pirfenidone API Company Information

7.1.2 Mylan Pirfenidone API Product Portfolio

7.1.3 Mylan Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.1.4 Mylan Main Business and Markets Served

7.1.5 Mylan Recent Developments/Updates

7.2 Apotex Pharmachem

7.2.1 Apotex Pharmachem Pirfenidone API Company Information

7.2.2 Apotex Pharmachem Pirfenidone API Product Portfolio

7.2.3 Apotex Pharmachem Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Apotex Pharmachem Main Business and Markets Served

7.2.5 Apotex Pharmachem Recent Developments/Updates

7.3 Aurobindo Pharma Limited

7.3.1 Aurobindo Pharma Limited Pirfenidone API Company Information

7.3.2 Aurobindo Pharma Limited Pirfenidone API Product Portfolio

7.3.3 Aurobindo Pharma Limited Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Aurobindo Pharma Limited Main Business and Markets Served

7.3.5 Aurobindo Pharma Limited Recent Developments/Updates

7.4 Chemeca Drugs

7.4.1 Chemeca Drugs Pirfenidone API Company Information

7.4.2 Chemeca Drugs Pirfenidone API Product Portfolio

7.4.3 Chemeca Drugs Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.4.4 Chemeca Drugs Main Business and Markets Served

7.4.5 Chemeca Drugs Recent Developments/Updates

7.5 CHEMO

7.5.1 CHEMO Pirfenidone API Company Information

7.5.2 CHEMO Pirfenidone API Product Portfolio

7.5.3 CHEMO Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.5.4 CHEMO Main Business and Markets Served

7.5.5 CHEMO Recent Developments/Updates

7.6 Glenmark Pharmaceuticals

7.6.1 Glenmark Pharmaceuticals Pirfenidone API Company Information

7.6.2 Glenmark Pharmaceuticals Pirfenidone API Product Portfolio

7.6.3 Glenmark Pharmaceuticals Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Glenmark Pharmaceuticals Main Business and Markets Served

7.6.5 Glenmark Pharmaceuticals Recent Developments/Updates

7.7 Hetero Drugs

7.7.1 Hetero Drugs Pirfenidone API Company Information

7.7.2 Hetero Drugs Pirfenidone API Product Portfolio

7.7.3 Hetero Drugs Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Hetero Drugs Main Business and Markets Served

7.7.5 Hetero Drugs Recent Developments/Updates

7.8 HONOUR LAB LTD

7.8.1 HONOUR LAB LTD Pirfenidone API Company Information

7.8.2 HONOUR LAB LTD Pirfenidone API Product Portfolio

7.8.3 HONOUR LAB LTD Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.8.4 HONOUR LAB LTD Main Business and Markets Served

7.8.5 HONOUR LAB LTD Recent Developments/Updates

7.9 Jubilant Generics

7.9.1 Jubilant Generics Pirfenidone API Company Information

7.9.2 Jubilant Generics Pirfenidone API Product Portfolio

7.9.3 Jubilant Generics Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.9.4 Jubilant Generics Main Business and Markets Served

7.9.5 Jubilant Generics Recent Developments/Updates

7.10 Laurus Labs

7.10.1 Laurus Labs Pirfenidone API Company Information

7.10.2 Laurus Labs Pirfenidone API Product Portfolio

7.10.3 Laurus Labs Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.10.4 Laurus Labs Main Business and Markets Served

7.10.5 Laurus Labs Recent Developments/Updates

7.11 Lupin Ltd

7.11.1 Lupin Ltd Pirfenidone API Company Information

7.11.2 Lupin Ltd Pirfenidone API Product Portfolio

7.11.3 Lupin Ltd Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.11.4 Lupin Ltd Main Business and Markets Served

7.11.5 Lupin Ltd Recent Developments/Updates

7.12 Micro Labs Limited

7.12.1 Micro Labs Limited Pirfenidone API Company Information

7.12.2 Micro Labs Limited Pirfenidone API Product Portfolio

7.12.3 Micro Labs Limited Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.12.4 Micro Labs Limited Main Business and Markets Served

7.12.5 Micro Labs Limited Recent Developments/Updates

7.13 NEWEDGE Overseas

7.13.1 NEWEDGE Overseas Pirfenidone API Company Information

7.13.2 NEWEDGE Overseas Pirfenidone API Product Portfolio

7.13.3 NEWEDGE Overseas Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.13.4 NEWEDGE Overseas Main Business and Markets Served

7.13.5 NEWEDGE Overseas Recent Developments/Updates

7.14 Optimus Pharma

7.14.1 Optimus Pharma Pirfenidone API Company Information

7.14.2 Optimus Pharma Pirfenidone API Product Portfolio

7.14.3 Optimus Pharma Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.14.4 Optimus Pharma Main Business and Markets Served

7.14.5 Optimus Pharma Recent Developments/Updates

7.15 Raks Pharma

7.15.1 Raks Pharma Pirfenidone API Company Information

7.15.2 Raks Pharma Pirfenidone API Product Portfolio

7.15.3 Raks Pharma Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.15.4 Raks Pharma Main Business and Markets Served

7.15.5 Raks Pharma Recent Developments/Updates

7.16 Shilpa Medicare

7.16.1 Shilpa Medicare Pirfenidone API Company Information

7.16.2 Shilpa Medicare Pirfenidone API Product Portfolio

7.16.3 Shilpa Medicare Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.16.4 Shilpa Medicare Main Business and Markets Served

7.16.5 Shilpa Medicare Recent Developments/Updates

7.17 SMS Pharmaceuticals

7.17.1 SMS Pharmaceuticals Pirfenidone API Company Information

7.17.2 SMS Pharmaceuticals Pirfenidone API Product Portfolio

7.17.3 SMS Pharmaceuticals Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.17.4 SMS Pharmaceuticals Main Business and Markets Served

7.17.5 SMS Pharmaceuticals Recent Developments/Updates

7.18 Veranova

7.18.1 Veranova Pirfenidone API Company Information

7.18.2 Veranova Pirfenidone API Product Portfolio

7.18.3 Veranova Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.18.4 Veranova Main Business and Markets Served

7.18.5 Veranova Recent Developments/Updates

7.19 Signa S.A. de C.V.

7.19.1 Signa S.A. de C.V. Pirfenidone API Company Information

7.19.2 Signa S.A. de C.V. Pirfenidone API Product Portfolio

7.19.3 Signa S.A. de C.V. Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.19.4 Signa S.A. de C.V. Main Business and Markets Served

7.19.5 Signa S.A. de C.V. Recent Developments/Updates

7.20 Guangzhou Tosun Pharmaceutical

7.20.1 Guangzhou Tosun Pharmaceutical Pirfenidone API Company Information

7.20.2 Guangzhou Tosun Pharmaceutical Pirfenidone API Product Portfolio

7.20.3 Guangzhou Tosun Pharmaceutical Pirfenidone API Production, Value, Price and Gross Margin (2020-2025)

7.20.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served

7.20.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Pirfenidone API Industry Chain Analysis

8.2 Pirfenidone API Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Pirfenidone API Production Mode & Process Analysis

8.4 Pirfenidone API Sales and Marketing

8.4.1 Pirfenidone API Sales Channels

8.4.2 Pirfenidone API Distributors

8.5 Pirfenidone API Customer Analysis

9 Pirfenidone API Market Dynamics

9.1 Pirfenidone API Industry Trends

9.2 Pirfenidone API Market Drivers

9.3 Pirfenidone API Market Challenges

9.4 Pirfenidone API Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Veranova

Apotex Pharmachem

Aurobindo Pharma Limited

Optimus Pharma

Shilpa Medicare

Glenmark Pharmaceuticals

Guangzhou Tosun Pharmaceutical

List of Tables

Table 1. Global Pirfenidone API Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Pirfenidone API Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 3. Global Pirfenidone API Production Capacity (Kg) by Manufacturers in 2024

Table 4. Global Pirfenidone API Production by Manufacturers (2020-2025) & (Kg)

Table 5. Global Pirfenidone API Production Market Share by Manufacturers (2020-2025)

Table 6. Global Pirfenidone API Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 7. Global Pirfenidone API Production Value Share by Manufacturers (2020-2025)

Table 8. Global Key Players of Pirfenidone API, Industry Ranking, 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pirfenidone API as of 2024)

Table 10. Global Market Pirfenidone API Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 11. Global Key Manufacturers of Pirfenidone API, Manufacturing Base Distribution and Headquarters

Table 12. Global Key Manufacturers of Pirfenidone API, Product Offered and Application

Table 13. Global Key Manufacturers of Pirfenidone API, Date of Enter into This Industry

Table 14. Global Pirfenidone API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pirfenidone API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Pirfenidone API Production Value (US$ Million) by Region (2020-2025)

Table 18. Global Pirfenidone API Production Value Market Share by Region (2020-2025)

Table 19. Global Pirfenidone API Production Value (US$ Million) Forecast by Region (2026-2031)

Table 20. Global Pirfenidone API Production Value Market Share Forecast by Region (2026-2031)

Table 21. Global Pirfenidone API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Pirfenidone API Production (Kg) by Region (2020-2025)

Table 23. Global Pirfenidone API Production Market Share by Region (2020-2025)

Table 24. Global Pirfenidone API Production (Kg) Forecast by Region (2026-2031)

Table 25. Global Pirfenidone API Production Market Share Forecast by Region (2026-2031)

Table 26. Global Pirfenidone API Market Average Price (US$/Kg) by Region (2020-2025)

Table 27. Global Pirfenidone API Market Average Price (US$/Kg) by Region (2026-2031)

Table 28. Global Pirfenidone API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 29. Global Pirfenidone API Consumption by Region (2020-2025) & (Kg)

Table 30. Global Pirfenidone API Consumption Market Share by Region (2020-2025)

Table 31. Global Pirfenidone API Forecasted Consumption by Region (2026-2031) & (Kg)

Table 32. Global Pirfenidone API Forecasted Consumption Market Share by Region (2026-2031)

Table 33. North America Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 34. North America Pirfenidone API Consumption by Country (2020-2025) & (Kg)

Table 35. North America Pirfenidone API Consumption by Country (2026-2031) & (Kg)

Table 36. Europe Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 37. Europe Pirfenidone API Consumption by Country (2020-2025) & (Kg)

Table 38. Europe Pirfenidone API Consumption by Country (2026-2031) & (Kg)

Table 39. Asia Pacific Pirfenidone API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kg)

Table 40. Asia Pacific Pirfenidone API Consumption by Region (2020-2025) & (Kg)

Table 41. Asia Pacific Pirfenidone API Consumption by Region (2026-2031) & (Kg)

Table 42. Latin America, Middle East & Africa Pirfenidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kg)

Table 43. Latin America, Middle East & Africa Pirfenidone API Consumption by Country (2020-2025) & (Kg)

Table 44. Latin America, Middle East & Africa Pirfenidone API Consumption by Country (2026-2031) & (Kg)

Table 45. Global Pirfenidone API Production (Kg) by Type (2020-2025)

Table 46. Global Pirfenidone API Production (Kg) by Type (2026-2031)

Table 47. Global Pirfenidone API Production Market Share by Type (2020-2025)

Table 48. Global Pirfenidone API Production Market Share by Type (2026-2031)

Table 49. Global Pirfenidone API Production Value (US$ Million) by Type (2020-2025)

Table 50. Global Pirfenidone API Production Value (US$ Million) by Type (2026-2031)

Table 51. Global Pirfenidone API Production Value Market Share by Type (2020-2025)

Table 52. Global Pirfenidone API Production Value Market Share by Type (2026-2031)

Table 53. Global Pirfenidone API Price (US$/Kg) by Type (2020-2025)

Table 54. Global Pirfenidone API Price (US$/Kg) by Type (2026-2031)

Table 55. Global Pirfenidone API Production (Kg) by Application (2020-2025)

Table 56. Global Pirfenidone API Production (Kg) by Application (2026-2031)

Table 57. Global Pirfenidone API Production Market Share by Application (2020-2025)

Table 58. Global Pirfenidone API Production Market Share by Application (2026-2031)

Table 59. Global Pirfenidone API Production Value (US$ Million) by Application (2020-2025)

Table 60. Global Pirfenidone API Production Value (US$ Million) by Application (2026-2031)

Table 61. Global Pirfenidone API Production Value Market Share by Application (2020-2025)

Table 62. Global Pirfenidone API Production Value Market Share by Application (2026-2031)

Table 63. Global Pirfenidone API Price (US$/Kg) by Application (2020-2025)

Table 64. Global Pirfenidone API Price (US$/Kg) by Application (2026-2031)

Table 65. Mylan Pirfenidone API Company Information

Table 66. Mylan Pirfenidone API Specification and Application

Table 67. Mylan Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 68. Mylan Main Business and Markets Served

Table 69. Mylan Recent Developments/Updates

Table 70. Apotex Pharmachem Pirfenidone API Company Information

Table 71. Apotex Pharmachem Pirfenidone API Specification and Application

Table 72. Apotex Pharmachem Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Apotex Pharmachem Main Business and Markets Served

Table 74. Apotex Pharmachem Recent Developments/Updates

Table 75. Aurobindo Pharma Limited Pirfenidone API Company Information

Table 76. Aurobindo Pharma Limited Pirfenidone API Specification and Application

Table 77. Aurobindo Pharma Limited Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. Aurobindo Pharma Limited Main Business and Markets Served

Table 79. Aurobindo Pharma Limited Recent Developments/Updates

Table 80. Chemeca Drugs Pirfenidone API Company Information

Table 81. Chemeca Drugs Pirfenidone API Specification and Application

Table 82. Chemeca Drugs Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Chemeca Drugs Main Business and Markets Served

Table 84. Chemeca Drugs Recent Developments/Updates

Table 85. CHEMO Pirfenidone API Company Information

Table 86. CHEMO Pirfenidone API Specification and Application

Table 87. CHEMO Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. CHEMO Main Business and Markets Served

Table 89. CHEMO Recent Developments/Updates

Table 90. Glenmark Pharmaceuticals Pirfenidone API Company Information

Table 91. Glenmark Pharmaceuticals Pirfenidone API Specification and Application

Table 92. Glenmark Pharmaceuticals Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Glenmark Pharmaceuticals Main Business and Markets Served

Table 94. Glenmark Pharmaceuticals Recent Developments/Updates

Table 95. Hetero Drugs Pirfenidone API Company Information

Table 96. Hetero Drugs Pirfenidone API Specification and Application

Table 97. Hetero Drugs Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Hetero Drugs Main Business and Markets Served

Table 99. Hetero Drugs Recent Developments/Updates

Table 100. HONOUR LAB LTD Pirfenidone API Company Information

Table 101. HONOUR LAB LTD Pirfenidone API Specification and Application

Table 102. HONOUR LAB LTD Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. HONOUR LAB LTD Main Business and Markets Served

Table 104. HONOUR LAB LTD Recent Developments/Updates

Table 105. Jubilant Generics Pirfenidone API Company Information

Table 106. Jubilant Generics Pirfenidone API Specification and Application

Table 107. Jubilant Generics Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Jubilant Generics Main Business and Markets Served

Table 109. Jubilant Generics Recent Developments/Updates

Table 110. Laurus Labs Pirfenidone API Company Information

Table 111. Laurus Labs Pirfenidone API Specification and Application

Table 112. Laurus Labs Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Laurus Labs Main Business and Markets Served

Table 114. Laurus Labs Recent Developments/Updates

Table 115. Lupin Ltd Pirfenidone API Company Information

Table 116. Lupin Ltd Pirfenidone API Specification and Application

Table 117. Lupin Ltd Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Lupin Ltd Main Business and Markets Served

Table 119. Lupin Ltd Recent Developments/Updates

Table 120. Micro Labs Limited Pirfenidone API Company Information

Table 121. Micro Labs Limited Pirfenidone API Specification and Application

Table 122. Micro Labs Limited Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Micro Labs Limited Main Business and Markets Served

Table 124. Micro Labs Limited Recent Developments/Updates

Table 125. NEWEDGE Overseas Pirfenidone API Company Information

Table 126. NEWEDGE Overseas Pirfenidone API Specification and Application

Table 127. NEWEDGE Overseas Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. NEWEDGE Overseas Main Business and Markets Served

Table 129. NEWEDGE Overseas Recent Developments/Updates

Table 130. Optimus Pharma Pirfenidone API Company Information

Table 131. Optimus Pharma Pirfenidone API Specification and Application

Table 132. Optimus Pharma Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Optimus Pharma Main Business and Markets Served

Table 134. Optimus Pharma Recent Developments/Updates

Table 135. Raks Pharma Pirfenidone API Company Information

Table 136. Raks Pharma Pirfenidone API Specification and Application

Table 137. Raks Pharma Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. Raks Pharma Main Business and Markets Served

Table 139. Raks Pharma Recent Developments/Updates

Table 140. Shilpa Medicare Pirfenidone API Company Information

Table 141. Shilpa Medicare Pirfenidone API Specification and Application

Table 142. Shilpa Medicare Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 143. Shilpa Medicare Main Business and Markets Served

Table 144. Shilpa Medicare Recent Developments/Updates

Table 145. SMS Pharmaceuticals Pirfenidone API Company Information

Table 146. SMS Pharmaceuticals Pirfenidone API Specification and Application

Table 147. SMS Pharmaceuticals Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 148. SMS Pharmaceuticals Main Business and Markets Served

Table 149. SMS Pharmaceuticals Recent Developments/Updates

Table 150. Veranova Pirfenidone API Company Information

Table 151. Veranova Pirfenidone API Specification and Application

Table 152. Veranova Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 153. Veranova Main Business and Markets Served

Table 154. Veranova Recent Developments/Updates

Table 155. Signa S.A. de C.V. Pirfenidone API Company Information

Table 156. Signa S.A. de C.V. Pirfenidone API Specification and Application

Table 157. Signa S.A. de C.V. Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 158. Signa S.A. de C.V. Main Business and Markets Served

Table 159. Signa S.A. de C.V. Recent Developments/Updates

Table 160. Guangzhou Tosun Pharmaceutical Pirfenidone API Company Information

Table 161. Guangzhou Tosun Pharmaceutical Pirfenidone API Specification and Application

Table 162. Guangzhou Tosun Pharmaceutical Pirfenidone API Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 163. Guangzhou Tosun Pharmaceutical Main Business and Markets Served

Table 164. Guangzhou Tosun Pharmaceutical Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Pirfenidone API Distributors List

Table 168. Pirfenidone API Customers List

Table 169. Pirfenidone API Market Trends

Table 170. Pirfenidone API Market Drivers

Table 171. Pirfenidone API Market Challenges

Table 172. Pirfenidone API Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pirfenidone API

Figure 2. Global Pirfenidone API Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Pirfenidone API Market Share by Type: 2024 VS 2031

Figure 4. Above 98 % Product Picture

Figure 5. Above 99 % Product Picture

Figure 6. Global Pirfenidone API Market Value by Application, (US$ Million) & (2020-2031)

Figure 7. Global Pirfenidone API Market Share by Application: 2024 VS 2031

Figure 8. Tablets

Figure 9. Capsules

Figure 10. Others

Figure 11. Global Pirfenidone API Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Pirfenidone API Production Value (US$ Million) & (2020-2031)

Figure 13. Global Pirfenidone API Production Capacity (Kg) & (2020-2031)

Figure 14. Global Pirfenidone API Production (Kg) & (2020-2031)

Figure 15. Global Pirfenidone API Average Price (US$/Kg) & (2020-2031)

Figure 16. Pirfenidone API Report Years Considered

Figure 17. Pirfenidone API Production Share by Manufacturers in 2024

Figure 18. Global Pirfenidone API Production Value Share by Manufacturers (2024)

Figure 19. Pirfenidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. The Global 5 and 10 Largest Players: Market Share by Pirfenidone API Revenue in 2024

Figure 21. Global Pirfenidone API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 22. Global Pirfenidone API Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 23. Global Pirfenidone API Production Comparison by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 24. Global Pirfenidone API Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 25. North America Pirfenidone API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 26. Europe Pirfenidone API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 27. China Pirfenidone API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 28. India Pirfenidone API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 29. Mexico Pirfenidone API Production Value (US$ Million) Growth Rate (2020-2031)

Figure 30. Global Pirfenidone API Consumption by Region: 2020 VS 2024 VS 2031 (Kg)

Figure 31. Global Pirfenidone API Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 32. North America Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 33. North America Pirfenidone API Consumption Market Share by Country (2020-2031)

Figure 34. U.S. Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 35. Canada Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 36. Europe Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 37. Europe Pirfenidone API Consumption Market Share by Country (2020-2031)

Figure 38. Germany Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 39. France Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 40. U.K. Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 41. Italy Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 42. Russia Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 43. Asia Pacific Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 44. Asia Pacific Pirfenidone API Consumption Market Share by Region (2020-2031)

Figure 45. China Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 46. Japan Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 47. South Korea Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 48. China Taiwan Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 49. Southeast Asia Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 50. India Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 51. Latin America, Middle East & Africa Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 52. Latin America, Middle East & Africa Pirfenidone API Consumption Market Share by Country (2020-2031)

Figure 53. Mexico Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 54. Brazil Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 55. Turkey Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 56. GCC Countries Pirfenidone API Consumption and Growth Rate (2020-2031) & (Kg)

Figure 57. Global Production Market Share of Pirfenidone API by Type (2020-2031)

Figure 58. Global Production Value Market Share of Pirfenidone API by Type (2020-2031)

Figure 59. Global Pirfenidone API Price (US$/Kg) by Type (2020-2031)

Figure 60. Global Production Market Share of Pirfenidone API by Application (2020-2031)

Figure 61. Global Production Value Market Share of Pirfenidone API by Application (2020-2031)

Figure 62. Global Pirfenidone API Price (US$/Kg) by Application (2020-2031)

Figure 63. Pirfenidone API Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

Report Code:

QYRE-Auto-22A7465

Published:

Fri May 09 00:00:00 UTC 2025

Est. Total

$19450.0